Calvo A - Search Results

1

Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer.

Jablonska PA, Bosch-Barrera J, Serrano D, Valiente M, Calvo A, Aristu J. Jablonska PA, et al. Among authors: calvo a. Cancers (Basel). 2021 Apr 29;13(9):2141. doi: 10.3390/cancers13092141. Cancers (Basel). 2021. PMID: 33946751 Free PMC article. Review.

2

Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.

Gonzalez-Moreno O, Segura V, Serrano D, Nguewa P, de las Rivas J, Calvo A. Gonzalez-Moreno O, et al. Among authors: calvo a. Int J Cancer. 2007 Sep 15;121(6):1197-204. doi: 10.1002/ijc.22764. Int J Cancer. 2007. PMID: 17520673 Free article.

3

The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer.

Diaz R, Nguewa PA, Diaz-Gonzalez JA, Hamel E, Gonzalez-Moreno O, Catena R, Serrano D, Redrado M, Sherris D, Calvo A. Diaz R, et al. Among authors: calvo a. Br J Cancer. 2009 Mar 24;100(6):932-40. doi: 10.1038/sj.bjc.6604938. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240717 Free PMC article.

4

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop.

Gonzalez-Moreno O, Lecanda J, Green JE, Segura V, Catena R, Serrano D, Calvo A. Gonzalez-Moreno O, et al. Among authors: calvo a. Exp Cell Res. 2010 Feb 15;316(4):554-67. doi: 10.1016/j.yexcr.2009.11.020. Epub 2009 Dec 16. Exp Cell Res. 2010. PMID: 20006606

5

Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer.

Serrano D, Bleau AM, Fernandez-Garcia I, Fernandez-Marcelo T, Iniesta P, Ortiz-de-Solorzano C, Calvo A. Serrano D, et al. Among authors: calvo a. Mol Cancer. 2011 Aug 9;10:96. doi: 10.1186/1476-4598-10-96. Mol Cancer. 2011. PMID: 21827695 Free PMC article.

6

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.

Zubeldia IG, Bleau AM, Redrado M, Serrano D, Agliano A, Gil-Puig C, Vidal-Vanaclocha F, Lecanda J, Calvo A. Zubeldia IG, et al. Among authors: calvo a. Exp Cell Res. 2013 Feb 1;319(3):12-22. doi: 10.1016/j.yexcr.2012.11.004. Epub 2012 Nov 12. Exp Cell Res. 2013. PMID: 23153552

7

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM, Arbea L, Lozano MD, Calvo A, Gil-Bazo I. Castañon E, et al. Among authors: calvo a. J Transl Med. 2013 Jan 11;11:13. doi: 10.1186/1479-5876-11-13. J Transl Med. 2013. PMID: 23311395 Free PMC article.

8

Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8⁺ T Cells.

Baraibar I, Roman M, Rodríguez-Remírez M, López I, Vilalta A, Guruceaga E, Ecay M, Collantes M, Lozano T, Alignani D, Puyalto A, Oliver A, Ortiz-Espinosa S, Moreno H, Torregrosa M, Rolfo C, Caglevic C, García-Ros D, Villalba-Esparza M, De Andrea C, Vicent S, Pío R, Lasarte JJ, Calvo A, Ajona D, Gil-Bazo I. Baraibar I, et al. Among authors: calvo a. Cancers (Basel). 2020 Oct 28;12(11):3169. doi: 10.3390/cancers12113169. Cancers (Basel). 2020. PMID: 33126649 Free PMC article.

9

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Redin E, Garmendia I, Lozano T, Serrano D, Senent Y, Redrado M, Villalba M, De Andrea CE, Exposito F, Ajona D, Ortiz-Espinosa S, Remirez A, Bertolo C, Sainz C, Garcia-Pedrero J, Pio R, Lasarte J, Agorreta J, Montuenga LM, Calvo A. Redin E, et al. Among authors: calvo a. J Immunother Cancer. 2021 Mar;9(3):e001496. doi: 10.1136/jitc-2020-001496. J Immunother Cancer. 2021. PMID: 33658304 Free PMC article.

10

Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.

Sánchez-Canteli M, Juesas L, Redin E, Calvo A, López F, Astudillo A, Montuenga LM, García-Pedrero JM, Rodrigo JP. Sánchez-Canteli M, et al. Among authors: calvo a. Cancers (Basel). 2021 Apr 25;13(9):2079. doi: 10.3390/cancers13092079. Cancers (Basel). 2021. PMID: 33923066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,091 results

Search Page